First in Turkey: World's newest heart valve technology G5 MitraClip introduced to patients

The world's newest heart valve technology, the G5 MitraClip, has been introduced to patients for the first time in Turkey at Medipol Mega University Hospital. This minimally invasive device is designed to treat mitral regurgitation in patients who cannot undergo open-heart surgery. The procedure involves clipping the mitral valve to reduce leakage, offering a new treatment option for high-risk patients. The introduction marks a significant milestone in cardiac care in the region, expanding access to advanced medical technology.

Global Impact

This introduction expands the reach of advanced cardiac care to a new patient population in Turkey, potentially reducing mortality and improving quality of life for those with mitral regurgitation. Economically, it may drive further investment in minimally invasive cardiac technologies and training programs in the region.